Dementia Therapy
Research from M.E. Devine and co-authors reveals new findings on dementia therapy
Published in Mental Health Business Week, December 15th, 2007
Researchers detail in 'Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study,' new data in dementia. "Cerebral white matter changes (WMC) represent cerebrovascular disease (CVD) and are common in dementia. Cholinesterase inhibitors (ChEIs) are effective in Alzheimer's Disease (AD) with or without CVD, and in Dementia with Lewy Bodies (DLB)," scientists in the United Kingdom report.
"Predictors of treatment response are controversial. To investigate the effect of WMC severity on rate of progression of dementia during treatment with ChEIs. CT or MRI brain scans were rated for WMC severity...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Acute Myeloid Leukemia
St. Jude Researchers Identify Key Genetic Trigger of Acute Myeloid Leukemia - Addiction Medicine
VH1 Teams Up with Dr. Drew for 'Celebrity Rehab With Dr. Drew,' a Series Depicting the Process of Overcoming Addiction - Asperger Syndrome
Autism U: As College Application Deadlines Near, Growing Adult Autism Population Focuses on Higher Education - Attention Deficit Hyperactivity Disorder
Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration - Attention Deficit Hyperactivity Disorder
New Study Finds Working Memory Training Produces Lasting Improvements in Kids with Attention Deficits - Attention Deficit Hyperactivity Disorder Therapy
Researchers from MDS Pharma Services detail new studies and findings in the area of attention deficit hyperactivity disorder therapy - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
